Literature DB >> 16818738

Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells.

Hyung W Lim1, Hal E Broxmeyer, Chang H Kim.   

Abstract

Forkhead Box P3(+) (FOXP3(+)) T cells are regulatory cells important for maintaining immune tolerance. While chemokine- and other homing-receptors are important for T cell migration, it has been unclear how they are regulated in FOXP3(+) T cells. We thoroughly investigated, ex vivo and in vitro, the regulation of chemokine receptor expression on human FOXP3(+) T cells in neonatal cord blood, adult peripheral blood, and tonsils. We found that human FOXP3(+) T cells undergo changes in trafficking receptors according to their stages of activation and differentiation. FOXP3(+) T cells are divided into CD45RA(+) (naive type) and CD45RO(+) (memory type) FOXP3(+) T cells in neonatal blood, adult blood, and tonsils. CD45RA(+)FOXP3(+) T cells mainly express lymphoid tissue homing receptors (CD62L, CCR7, and CXCR4), while CD45RO(+)FOXP3(+) T cells highly express both Th1 and Th2-associated trafficking receptors along with the lymphoid tissue homing receptors at reduced frequencies. Up-regulation of Th1/Th2-associated trafficking receptors begins with activation of CD45RA(+)FOXP3(+) T cells and is completed after their differentiation to CD45RO(+) cells. Some chemokine receptors such as CXCR5 and CXCR6 are preferentially expressed by many FOXP3(+) cells at a specific stage (CD69(+)CD45RO(+)) in tonsils. Our in vitro differentiation study demonstrated that CD45RA(+)FOXP3(+) T cells indeed undergo chemokine receptor switch from CD45RA(+) (secondary lymphoid tissue homing) to CD45RO(+) type (lymphoid and nonlymphoid tissue homing). The orderly regulation of trafficking receptors in FOXP3(+) T cells according to stages of differentiation and activation is potentially important for their tissue-specific migration and regulation of immune responses in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16818738     DOI: 10.4049/jimmunol.177.2.840

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

2.  Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.

Authors:  Thomas Duhen; Rebekka Duhen; Antonio Lanzavecchia; Federica Sallusto; Daniel J Campbell
Journal:  Blood       Date:  2012-03-21       Impact factor: 22.113

Review 3.  Molecular and functional heterogeneity of T regulatory cells.

Authors:  Lequn Li; Vassiliki A Boussiotis
Journal:  Clin Immunol       Date:  2011-08-30       Impact factor: 3.969

Review 4.  T follicular regulatory cells in mice and men.

Authors:  Ana Raquel Maceiras; Valter R Fonseca; Ana Agua-Doce; Luis Graca
Journal:  Immunology       Date:  2017-07-27       Impact factor: 7.397

5.  Human blood Tfr cells are indicators of ongoing humoral activity not fully licensed with suppressive function.

Authors:  Valter R Fonseca; Ana Agua-Doce; Ana Raquel Maceiras; Wim Pierson; Filipa Ribeiro; Vasco C Romão; Ana Rita Pires; Susana Lopes da Silva; João Eurico Fonseca; Ana E Sousa; Michelle A Linterman; Luis Graca
Journal:  Sci Immunol       Date:  2017-08-11

6.  Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells.

Authors:  Weiyun Z Ai; Jing-Zhou Hou; Robert Zeiser; Debra Czerwinski; Robert S Negrin; Ronald Levy
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

7.  Simian immunodeficiency virus infection potently modulates chemokine networks and immune environments in hilar lymph nodes of cynomolgus macaques.

Authors:  Shulin Qin; Beth A F Junecko; Carissa M Lucero; Cynthia R Klamar; Anita M Trichel; Michael A Murphey-Corb; Patrick M Tarwater; Denise E Kirschner; Todd A Reinhart
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

8.  Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.

Authors:  Aric L Gregson; Aki Hoji; Vyacheslav Palchevskiy; Scott Hu; S Samuel Weigt; Eileen Liao; Ariss Derhovanessian; Rajeev Saggar; Sophie Song; Robert Elashoff; Otto O Yang; John A Belperio
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

9.  Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria.

Authors:  Michael Walther; David Jeffries; Olivia C Finney; Madi Njie; Augustine Ebonyi; Susanne Deininger; Emma Lawrence; Alfred Ngwa-Amambua; Shamanthi Jayasooriya; Ian H Cheeseman; Natalia Gomez-Escobar; Joseph Okebe; David J Conway; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

10.  In situ patrolling of regulatory T cells is essential for protecting autoimmune exocrinopathy.

Authors:  Naozumi Ishimaru; Takeshi Nitta; Rieko Arakaki; Akiko Yamada; Martin Lipp; Yousuke Takahama; Yoshio Hayashi
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.